Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)

China · Delayed Price · Currency is CNY

31.40

+0.11 (0.35%)

Jul 8, 2026, 3:04 PM CST

-28.38% (1Y)

Market Cap	13.23B -35.4%
Revenue (ttm)	5.53B -1.1%
Net Income	543.34M +53.3%
EPS	1.28 +50.3%
Shares Out	421.29M
PE Ratio	24.46
Forward PE	20.70
Dividend	0.70 (2.24%)
Ex-Dividend Date	May 28, 2026

Volume	6,687,147
Open	32.03
Previous Close	31.29
Day's Range	30.90 - 32.45
52-Week Range	29.48 - 51.80
Beta	0.66
Analysts	Buy
Price Target	46.03 (+46.59%)
Earnings Date	Aug 25, 2026

About SHE:300957

Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup removers. It is also involved in the research, development, production, and sale of skincare related medical devices and electronic beauty instruments ... [Read more]

Industry Household & Personal Products

Sector Consumer Staples

Founded 2010

Employees 3,574

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300957

Full Company Profile

Financial Performance

In 2025, SHE:300957's revenue was 5.36 billion, a decrease of -6.58% compared to the previous year's 5.74 billion. Earnings were 505.72 million, an increase of 0.53%.

Financial Statements

Analyst Summary

According to 13 analysts, the average rating for 300957 stock is "Buy." The 12-month stock price target is ¥46.03, which is an increase of 46.59% from the latest price.

Price Target

¥46.03

(46.59% upside)

Analyst Consensus: Buy

Stock Forecasts